BiotechTube

DONEPEZIL HYDROCHLORIDE

ApprovedTerminated
0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Alzheimer's Disease

Conditions

Alzheimer's Disease

Trial Timeline

Mar 1, 2005 → Nov 1, 2008

NCT ID
NCT00165750

About DONEPEZIL HYDROCHLORIDE

DONEPEZIL HYDROCHLORIDE is a approved stage product being developed by Eisai for Alzheimer's Disease. The current trial status is terminated. This product is registered under clinical trial identifier NCT00165750. Target conditions include Alzheimer's Disease.

What happened to similar drugs?

20 of 20 similar drugs in Alzheimer's Disease were approved

Approved (20) Terminated (1) Active (0)
✅Alfoatirin® Tab. + Aripezil® Tab. + Aripezil® Tab.YuhanApproved
✅DonepezilEisaiApproved
✅Donepezil HCLEisaiApproved
✅Donepezil HClEisaiApproved
✅Donepezil HydrochlorideEisaiApproved
✅AriceptEisaiApproved
✅DonepezilEisaiApproved

Hype Score Breakdown

Clinical
20
Activity
0
Company
15
Novelty
0
Community
0

Clinical Trials (11)

NCT IDPhaseStatus
NCT02448784Pre-clinicalCompleted
NCT02162264Pre-clinicalCompleted
NCT02162251Pre-clinicalCompleted
NCT01251718Pre-clinicalCompleted
NCT01129596Pre-clinicalCompleted
NCT00477659ApprovedCompleted
NCT00165750ApprovedTerminated
NCT00165724ApprovedCompleted
NCT00165737Phase 3Completed
NCT00165659Phase 2Completed
NCT00096473Phase 3Completed

Competing Products

20 competing products in Alzheimer's Disease

See all competitors
ProductCompanyStageHype Score
LY450139 + PlaceboEli LillyPhase 3
40
Solanezumab + PlaceboEli LillyPhase 3
32
LY450139 dihydrate + placeboEli LillyPhase 2
35
GSK4527226AlectorPhase 2
29
GSK4527226AlectorPhase 2
32
AL002AlectorPhase 2
17
Solanezumab + PlaceboEli LillyPhase 3
32
simufilamCassava SciencesPhase 2
17
Remternetug + PlaceboEli LillyPhase 3
44
solanezumabEli LillyPhase 2
35
LY2886721 + PlaceboEli LillyPhase 1
29
Gantenerumab + Gantenerumab + Gantenerumab + PlaceboChugai PharmaceuticalPhase 1
29
Alfoatirin® Tab. + Aripezil® Tab. + Aripezil® Tab.YuhanApproved
39
FK962Astellas PharmaPhase 2
27
ASP0777 + PlaceboAstellas PharmaPhase 1
29
Elenbecestat + PlaceboEisaiPhase 3
32
DonepezilEisaiApproved
43
Aricept (donepezil SR 23 mg) + Aricept (donepezil IR 10 mg)EisaiPhase 3
40
Donepezil hydrochlorideEisaiPhase 3
40
Donepezil HydrochlorideEisaiPre-clinical
26